Hong Kong, Oct 20, 2026 – (ACN Newswire) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), an international medical gadget business concentrating on interventional gadgets for percutaneous coronary intervention (“PCI”) and percutaneous transluminal angioplasty (“PTA”), today revealed that it has actually finished the acquisition of a 100% interest in MC Health S.r.l. (“MC Health”), its supplier in Italy. Following the conclusion of the deal, MC Health has actually ended up being a wholly-owned subsidiary of the Group.
Italy is among Europe’s essential interventional cardiology markets, with around 157,000 PCI treatments carried out yearly. The shift to a direct sales design through the acquisition provides an engaging chance for OrbusNeich to deepen client relationships, improve market responsiveness, and catch the complete development capacity of its industry-leading coronary portfolio. Following the conclusion of the acquisition, OrbusNeich has actually instantly developed a direct sales existence in Italy, supported by MC Health’s across the country cath laboratories protection.
Mr. David Chien, Chairman, Executive Director and Co-Chief Executive Officer of OrbusNeichstated, “This acquisition highlights OrbusNeich’s disciplined development method and dedication to producing long-lasting worth. As our relied on partner given that 2019, MC Health is a natural suitable for our business, enhancing our direct existence in Europe, opening business synergies, and broadening chances for cooperation on ingenious innovations, consisting of IVUS systems. Integrated with MC Health’s strong proficiency in the peripheral vascular field, the acquisition is likewise anticipated to speed up the development of our PTA portfolio throughout Italy and Europe, allowing us to reach and benefit more clients.”
Because its listing in Hong Kong in 2022, OrbusNeich has actually continued to speed up the growth of its worldwide direct sales network. The acquisition of its Indonesian supplier in 2023 and Taiwan supplier in 2025 marked a substantial turning point in this change, which supported the development in Asia-Pacific area. With Italy joining its direct sales network, along with the groups developed previously this year in the Netherlands, Belgium and Luxembourg, OrbusNeich now has direct sales operations in 16 markets worldwide, more reinforcing its European existence and supporting sustainable long-lasting development.
About MC Health S.r.l.
Established in 2009, MC Health is a business participated in medical gadget circulation in Italy. Developed to resolve developing and requiring market requirements, the company runs as a nimble, effective partner serving public and private-sector health centers and centers. Its objective is to please the requirement for quality medical gadgets and services by marketing innovative treatments to both public and personal health centers and centers, to increase the lifestyle of countless individuals.
To find out more, please go to the Company’s main site: https://www.mchealth.it/
About OrbusNeich Medical Group Holdings Limited
OrbusNeich is an international medical gadget business focusing on interventional gadgets for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) treatments. Headquartered in Hong Kong, China, the Group offers its items in more than 70 nations and areas worldwide. It is likewise actively broadening into structural cardiovascular disease. With an internal R&D group boasting over 25 years of item advancement proficiency, the Group has actually established world-leading exclusive innovations.
To learn more, please check out the Group’s main site: https://orbusneich.com/
Subject: Press release summary
Source: OrbusNeich Medical Group Holdings Limited
Sectors: Healthcare & & Pharm, MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights booked. A department of Asia Corporate News Network.
Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND
Subscribe to get the latest posts sent to your email.
